Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Market release of breast biopsy device announced
December 28th, 2004
Sanarus Medical, Inc., announced the market release of the Cassi Rotational Core Biopsy Device, which is based on the company's proprietary Stick Freeze Technology. More than 1.6 million breast biopsies are performed each year in the United States. A biopsy may be prescribed when the patient's breast care physician detects a breast lump or abnormality. The procedure involves taking tissue samples or "cores" from the suspicious area to determine if the lump is cancerous. The Cassi Biopsy Device is the first hand-held large-core biopsy device on the market to be fully automated and disposable post procedure. It requires no set-up time, performs...
Source: Cancer Weekly (2004-12-28)
|
